Independent fund research. Built on SEC filings.

How we research funds

ETF · Mid-Cap · WisdomTree

WisdomTree U.S. MidCap Quality Growth Fund (QMID)

Ticker QMID · Since 2024-01-24 · · Holdings as of Jun 30, 2026

Expense ratio
0.38%$38/yr per $10k
1-yr return
+5.1%as of Dec 2025
Net assets
$2.2Mall share classes
Holdings
125

Bottom line

Is QMID a good fund? The bottom line

QMID is an actively managed mid-cap ETF from WisdomTree.

It charges 0.38% — about $38 a year on every $10,000 invested, cheaper than 89% of mid-cap funds we track.

It returned +5.1% over one year (as of Dec 31, 2025, per its prospectus).

With $2.2 million in net assets and 125 holdings, its largest position is Somnigroup International Inc (1.4%) and the top 10 make up 12.8% of the portfolio.

What stands out

  • Low cost: cheaper than 89% of mid-cap peers

What to watch

  • Small fund ($2.2 million) — small funds are likelier to close

Updated Nov 19, 2026

What QMID invests in

The WisdomTree U.S. MidCap Quality Growth Fund (the Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree U.S. MidCap Quality Growth Index (the Index).

The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return, and other characteristics resemble the risk, return, and other characteristics of the Index as a whole. Under normal circumstances, the Fund invests at least 80% of its net assets (plus the amount of any borrowings for investment purposes) in the constituent securities of the Index, each of which is a security issued by a mid-cap company, identified in accordance with the Index Providers (as defined below) market-capitalization selection parameters, that is incorporated and headquartered in the United States. The Index Providers market-capitalization selection parameters generally…

From the fund's prospectus (filed Jul 29, 2026).

QMID performance

Fund calendar-year total returns, 2025–2025 2025: +5.1% +5.1% 2025
Fund gain (+)
Average annual total returns
1 yr5 yr10 yr
QMID+5.1%——
Mid-Cap median+7.9%+8.1%+9.9%

Source: Fund prospectus, as of Dec 31, 2025

Full QMID performance history →

What QMID costs

On a $10,000 investment, QMID's 0.38% expense ratio costs about $38 a year. The prospectus estimates $480 in total costs over 10 years (assuming 5% annual returns). The median mid-cap fund charges 0.88%.

See the full QMID fee table →

QMID top 10 holdings

#Holding% of fund
1Somnigroup International Inc SGI1.40%
2Tenet Healthcare Corp THC1.39%
3Dycom Industries Inc DY1.33%
4Tko Group Holdings Inc TKO1.29%
5Neurocrine Biosciences Inc NBIX1.28%
6Ralph Lauren Corp RL1.27%
7Everest Group Ltd EG1.25%
8Dicks Sporting Goods Inc DKS1.20%
9Deckers Outdoor Corp DECK1.20%
10Medpace Holdings Inc MEDP1.20%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 12.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to QMID

More funds like QMID →

QMID FAQ

What is the expense ratio of QMID?
QMID's expense ratio is 0.38%, which works out to about $38 a year for every $10,000 invested. The prospectus estimates total costs of $480 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is QMID a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 89% of mid-cap peers; small fund ($2.2 million) — small funds are likelier to close. This is general information, not personalized advice.
What does QMID hold?
QMID's largest holdings are Somnigroup International Inc (1.4%), Tenet Healthcare Corp (1.4%), Dycom Industries Inc (1.3%), Tko Group Holdings Inc (1.3%), Neurocrine Biosciences Inc (1.3%). It holds 125 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages QMID?
QMID is offered by WisdomTree through WisdomTree Trust.